Thank you to the over 700 bioscience community executives that participated in BioWest 2008. A few highlights follow:
Congratulations to Oberon FMR, Inc. (Idaho Springs, CO) the winner of the 2008 Dorsey & Whitney Venture Showcase Award. Oberon FMR is preparing to produce a cost-effective, sustainable protein meal to serve as a replacement ingredient for fish meal in the production of feeds for the aquaculture industry – a consumer of more than $4 billion in fish meal.
Listen here for the Colorado Public Radio program where the six Venture Showcase finalists and Christine Shapard (to come) from the CBSA were interviewed.
G. Steven Burrill, Burrill and Company presented a future vision for the life science industry that was challenging and at the same time provided….. Click here for Burrill’s presentation.
Ernst & Young’s Washington Council partner Richard Meltzer has been a player in DC on federal health care issues for a long time. His presentation here provided the BioWest audience with an idea of what to expect from the new president, federal agencies and congress.
Over 300 individuals attended the CBSA’s first ever career fair and met with 24 companies looking for employees. This was so successful that it will become an annual event.
2008 BioWest Conference
G. Steven Burrill
Chief Executive Officer, Burrill and Company
November 13, 2008
Founder's Breakfast
8:30–9:45 am
G. Steven Burrill has the ideal vantage point to comment on Colorado's position vis-á-vis the rest of the world's life sciences industry. Based on ideas from his recent publication, Biotech 2008: A 20⁄20 Vision of 2020, he will recommend how Colorado can position itself to be a big winner in the Future. Of course, he will also have some fun insight into to the recent election and its impact on the bioscience industry.
G. Steven Burrill founded Burrill & Company as a logical extension of his 40-year involvement in the growth and prosperity of the biotechnology industry. Mr. Burrill has been an active advisor and catalyst in some of the industry's most notable companies and transactions. Mr. Burrill's close involvement and respected position within the industry has positioned the firm as a prominent deal-maker and facilitator of industry partnerships and alliances, all of which fosters a robust deal flow. Further contributing to this deal flow are: the scientific and business networks of its investment team; the Advisory Boards; the strategic and financial network of its limited partners; and the close relationships developed with numerous life science companies and management as a result of Burrill's visibility, reputation, and the firm's partnering and alliance work.
2008 BioWest Conference
The CBSA is hosting a Job Fair on the afternoon of November 14, 2008.
The Job Fair will be held at the Grand Hyatt (across the car park from main hotel)
555 17th Street, 37th Floor
For more information, please contact Leah Kientz.
G. Steven Burrill has the ideal vantage point to comment on Colorado's position vis-á-vis the rest of the world's life sciences industry. Based on ideas from his recent publication, Biotech 2008: A 20⁄20 Vision of 2020, he will recommend how Colorado can position itself to be a big winner in the Future. Of course, he will also have some fun insight into to the recent election and its impact on the bioscience industry.
